Autolus Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $24,253 | $21,194 | $20,923 | $8,982 |
Gross Profit | -1,039 | -7,449 | -3,522 | -8,969 |
EBITDA | -72,361 | -64,703 | -56,906 | -55,516 |
EBIT | -72,247 | -68,066 | -61,217 | -57,793 |
Net Income | -90,201 | -79,118 | -47,917 | -70,161 |
Net Change In Cash | 24,253 | 21,194 | 20,923 | 8,982 |
Free Cash Flow | -91,086 | -52,379 | -80,058 | -83,808 |
Cash | 104,132 | 86,124 | 123,825 | 95,799 |
Basic Shares | 266,143 | 266,141 | 266,141 | 266,126 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $75,564 | $10,120 | $1,698 | $6,194 |
Gross Profit | -21,030 | -130,900 | 1,698 | 6,194 |
EBITDA | -271,600 | -233,073 | -156,770 | -132,240 |
EBIT | -281,437 | -240,789 | -163,335 | -139,662 |
Net Income | -287,528 | -220,662 | -208,383 | -148,839 |
Net Change In Cash | 75,564 | 10,120 | 1,698 | 6,194 |
Free Cash Flow | -303,318 | -241,090 | -156,573 | -123,149 |
Cash | 104,132 | 227,380 | 239,566 | 382,436 |
Basic Shares | 266,138 | 255,161 | 173,941 | 94,993 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.34 |
2025-09-30 | -$0.30 |
2025-06-30 | -$0.18 |
